Medlumics lands a 14M€ new financing round

25.10.2024 - andera Life Sciences

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-focused Pipeline

14.10.2024 - andera Life Sciences - Press releases

Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study

26.07.2024 - andera Life Sciences - Press releases

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Boar…

25.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences

25.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upc…

15.07.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca

09.07.2024 - andera Life Sciences - Press releases

Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom

14.03.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the d…

14.03.2024 - andera Life Sciences - Press releases

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

21.02.2024 - andera Life Sciences - Press releases

MMI Raises $110 Million in Series C Financing

12.02.2024 - andera Life Sciences - Recruitment

Internship Offer – Andera Life Sciences

14.11.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immu…

27.10.2023 - andera Life Sciences - Press releases

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…

11.10.2023 - andera Life Sciences - Press releases

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

05.10.2023 - andera Life Sciences - Press releases

Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…